Evaxion to unveil potentially groundbreaking ai-immunology™ precision cancer vaccine concept

Copenhagen, denmark, nov. 28, 2023 (globe newswire) -- evaxion biotech a/s (nasdaq: evax) (“evaxion” or the “company”), a clinical-stage techbio company specializing in developing ai-immunology™ powered vaccines, proudly announces the presentation of its novel precision vaccine concept at the 65th american society of hematology (ash) annual meeting, taking place in san diego, california, from december 9-12, 2023.
EVAX Ratings Summary
EVAX Quant Ranking